# Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-tolerability-and-immunogenicity-of-a-recombinant-adenovirus-type-5/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Fengcai Zhu,Yu-Hua Li,Xu-Hua Guan,Li-Hua Hou,Wen-Juan Wang,Wen-Juan Wang,J X Li,Shi-Po Wu,Zhao Wang,Lei Wang,Lei Wang,Hu-Dachuan Jiang,Hu-Dachuan Jiang,Ling Wang,T Jiang,Yu Hu,Jin-Bo Gou,Junjie Xu,Junjie Xu,Wei Wang,Wei Chen,Wei Wang,Wei Chen |
| Citations | 1,453 |
| DOI | 10.1016/s0140-6736(20)31208-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thelancet.com/article/S0140673620312083/pdf |
| OpenAlex ID | https://openalex.org/W3027138240 |
| PMID | 32450106 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Wei Wang](https://scholariq.org/researchers/wei-wang-2/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)

## Paper topics

- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.